Conagen Archives | Page 3 of 3 | Be Korea-savvy
Conagen Begins Scale Up of Natural Sustainable Musk Macrocyclic Lactone Fragrance Materials

Conagen Begins Scale Up of Natural Sustainable Musk Macrocyclic Lactone Fragrance Materials

Bedford, Mass., Jan. 11 (Korea Bizwire) – Conagen announced today its breakthrough development in the commercial production of natural and sustainable macrocyclic musk lactones from natural substrates using its proprietary technology, further expanding its already extensive gamma-lactone portfolio. Musk fragrance compounds are typically used as base note ingredients in perfumes. The natural sources of these compounds are found [...]

Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin

Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin

Bedford, Mass., Sept. 29 (Korea Bizwire) — SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human milk oligosaccharide (HMO.) Human lactoferrin is a critical iron-binding compound for immunity and iron nutrition. HMOs are important nutritional compounds only found in human milk. The most abundant HMO in human milk [...]

Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas

Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas

Bedford, Mass., Aug. 19 (Korea Bizwire) – Conagen, a rapidly-growing Boston-based biotechnology firm, has established a novel and proprietary process for the scalable production of a non-GMO human milk oligosaccharide (HMO), an important nutritional compound only found in human milk. This micronutrition breakthrough will enable the creation of high-quality and cost-effective next generation infant formula products [...]

Conagen Receives a Strategic Investment from Sumitomo Chemical

Conagen Receives a Strategic Investment from Sumitomo Chemical

Bedford, Mass., March 31 (Korea Bizwire) — Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment will accelerate Conagen’s synthetic biology research and development contributing to a clean and sustainable planet. Both Sumitomo Chemical and Conagen share a vision of bio-designing and introducing sustainable green chemicals to the market for reducing [...]

Infant Formula Evolves and Advances in Nutrition

Infant Formula Evolves and Advances in Nutrition

Bedford, Mass., March 24 (Korea Bizwire) – Conagen announced today the discovery and development of a sustainable proprietary lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk. The first-of-its-kind natural lactoferrin protein is produced via fermentation process at commercial-scale. Mother’s milk is the best nutrition because it is the ideal way to bind and [...]